$40M sweet spot round size
Most of their 15 investments are in rounds between $18M and $51M
2013
Neon Therapeutics raised $36M on December 5, 2017
Investors: Nextech Invest, Access Industries, Casdin Capital, LLC, Hillhouse Capital Management, -, Wellington Management and Inbio Ventures
Neon Therapeutics raised $70M on January 5, 2017
Investors: Access Industries, Nextech Invest, -, Third Rock Ventures, Wellington Management and Inbio Ventures
Avelas Biosciences, Inc. raised $20M on August 18, 2016
Investors: Millhouse, Inc. PLC, Avalon Venture and Inbio Ventures
TransMedics, Inc. raised $13M on July 12, 2016
Investors: Abrams Capital, Lung Biotechnology PBC, BioStar Ventures, Kleiner Perkins, Flagship Ventures and Inbio Ventures
TransMedics, Inc. raised $51M on May 26, 2016
Investors: Lung Biotechnology PBC, Abrams Capital, Millhouse, Inc. PLC, Kleiner Perkins, Flagship Ventures, BioStar Ventures and Inbio Ventures
chuh raised $60M on March 15, 2016
Investors: Inbio Ventures
Allena Pharmaceuticals, Inc. raised $53M on December 9, 2015
Investors: Wellington Management, Frazier Healthcare Partners, - and Inbio Ventures
Protagonist Therapeutics raised $40M on July 16, 2015
Investors: Adage Capital Management, Canaan, RA Capital Management, L.P., Lilly Ventures, Foresite Capital, Starfish Ventures and Inbio Ventures
Jounce Therapeutics, Inc. raised $56M on April 23, 2015
Investors: Omega Funds, Nextech Invest, Casdin Capital, LLC, Redmile Group, Wellington Management, Foresite Capital and Inbio Ventures
Engene Inc raised $12M on January 26, 2015
Investors: Forbion, Lumira Ventures and Inbio Ventures